1-55061806-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_174936.4(PCSK9):​c.1863+250A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.824 in 152,232 control chromosomes in the GnomAD database, including 51,955 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.82 ( 51955 hom., cov: 33)

Consequence

PCSK9
NM_174936.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.353

Publications

3 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.968 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.1863+250A>G
intron
N/ANP_777596.2
PCSK9
NM_001407240.1
c.1986+250A>G
intron
N/ANP_001394169.1
PCSK9
NM_001407241.1
c.1905+250A>G
intron
N/ANP_001394170.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.1863+250A>G
intron
N/AENSP00000303208.5
PCSK9
ENST00000710286.1
c.2220+250A>G
intron
N/AENSP00000518176.1
PCSK9
ENST00000713786.1
c.1986+250A>G
intron
N/AENSP00000519088.1

Frequencies

GnomAD3 genomes
AF:
0.824
AC:
125413
AN:
152114
Hom.:
51924
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.763
Gnomad AMI
AF:
0.876
Gnomad AMR
AF:
0.880
Gnomad ASJ
AF:
0.814
Gnomad EAS
AF:
0.991
Gnomad SAS
AF:
0.887
Gnomad FIN
AF:
0.823
Gnomad MID
AF:
0.861
Gnomad NFE
AF:
0.831
Gnomad OTH
AF:
0.853
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.824
AC:
125497
AN:
152232
Hom.:
51955
Cov.:
33
AF XY:
0.827
AC XY:
61526
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.763
AC:
31686
AN:
41512
American (AMR)
AF:
0.880
AC:
13478
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.814
AC:
2825
AN:
3472
East Asian (EAS)
AF:
0.991
AC:
5132
AN:
5180
South Asian (SAS)
AF:
0.886
AC:
4272
AN:
4820
European-Finnish (FIN)
AF:
0.823
AC:
8727
AN:
10608
Middle Eastern (MID)
AF:
0.861
AC:
253
AN:
294
European-Non Finnish (NFE)
AF:
0.831
AC:
56522
AN:
68016
Other (OTH)
AF:
0.855
AC:
1805
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1129
2258
3386
4515
5644
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.828
Hom.:
70078
Bravo
AF:
0.826
Asia WGS
AF:
0.919
AC:
3197
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.44
DANN
Benign
0.47
PhyloP100
-0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs631220; hg19: chr1-55527479; COSMIC: COSV53764053; COSMIC: COSV53764053; API